AADAC promotes therapeutic activity of cisplatin and imatinib against ovarian cancer cells.
Sign Up to like & getrecommendations! Published in 2022 at "Histology and histopathology"
DOI: 10.14670/hh-18-460
Abstract: OBJECTIVE To explore how AADAC functions in the malignant progression of ovarian cancer, and the effect of AADAC on drug therapeutic activity against ovarian cancer cells. METHODS AADAC level in tumor and normal samples from… read more here.
Keywords: ovarian cancer; cancer cells; cancer; cisplatin imatinib ... See more keywords